Fairvalue-Calculator Fairvalue-Calculator
EN DE

Ayr Wellness Inc (AYRWF) Fair Value & Analysis

Healthcare · US · Market cap $2.0M

Price$0.0140
Fair Value$0.0144
Upside+2.7%
Quality92/100
Evidence: Low Range $0.0130 – $0.0157

Fair value as of: Jun 26, 2026

Analysis

Ayr Wellness Inc (AYRWF) currently trades at $0.0140, while our model-based Fair Value estimate is $0.0144 — implying the stock looks roughly 2.7% undervalued today. We read business quality at 92/100 (high quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: low) — always confirm before acting.

About the company

Ayr Wellness Inc. cultivates, manufactures, and retails cannabis products and branded cannabis packaged goods in United States. The company engages in the possession, manufacture, use, sale, or distribution of cannabis and/or holding of licenses in the adult-use and/or medicinal cannabis marketplace. Its portfolio includes consumer-packaged goods under the kynd, HAZE, and Later Days brand names, as well as legacy and local brands. The company also owns and operates a chain of cannabis retail stores under AYR and The Dispensary brand names. The company was formerly known as Ayr Strategies Inc. and changed its name to Ayr Wellness Inc. in February 2021. Ayr Wellness Inc. was incorporated in 2017 and is headquartered in Miami, Florida.

Open the full interactive analysis →

Similar stocks

Frequently asked questions

Is Ayr Wellness Inc (AYRWF) undervalued?
As of Jun 26, 2026, our model estimates a fair value of $0.0144 versus a price of $0.0140 — about +3% (undervalued). Model-based estimate, not financial advice.
What is the fair value of AYRWF?
Our 21-model fair value for Ayr Wellness Inc is $0.0144 (as of Jun 26, 2026), built from audited fundamentals. The current price is $0.0140.
What is the quality score of AYRWF?
Ayr Wellness Inc has a Quality Score of 92/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.